Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Free full text

Full text

Publication Types

Journal Article

Review

Research Support, Non-U.S. Gov't

Research Support, U.S. Gov't, P.H.S.

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2022

2018

2016

2012

2011

2009

2004

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Nicotinic Antagonists""[mesh_terms]

8 Results

Searching titles within these results

Single-Disulfide Conopeptide Czon1107, an Allosteric Antagonist of the Human α3β4 Nicotinic Acetylcholine Receptor.

Rilei Yu, Han-Shen Tae, Tao Jiang, David J Adams, Wenhao Du, Shuiping Fu, Yue Gao, Mengke Yang, Qiushi Cao, Yuan Ma

Marine drugs 2022;20(8):497

Free Full Text

Abstract

Human nicotinic receptors in chromaffin cells: characterization and pharmacology.

J Michael McIntosh, Almudena Albillos

Pflugers Archiv : European journal of physiology 2018;470(1):21-27

Free Full Text

Abstract

The Structural Features of α-Conotoxin Specifically Target Different Isoforms of Nicotinic Acetylcholine Receptors.

Rui-Jie Wu, Lei Wang, Hui Xiang

Current topics in medicinal chemistry 2016;16(2):156-69

Full Text

Abstract

Identification of a negative allosteric site on human α4β2 and α3β4 neuronal nicotinic acetylcholine receptors.

Ryan E Pavlovicz, Brandon J Henderson, Andrew B Bonnell, R Thomas Boyd, Dennis B McKay, Chenglong Li

PloS one 2012;6(9):e24949

Free Full Text

Abstract

Mechanistic contributions of residues in the M1 transmembrane domain of the nicotinic receptor to channel gating.

Guillermo Spitzmaul, Jeremías Corradi, Cecilia Bouzat

Molecular membrane biology 2004;21(1):39-50

Free Full Text

Abstract

alpha7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and Mesothelioma?

Laura Paleari, Alfredo Cesario, Massimo Fini, Patrizia Russo

Drug discovery today 2009;14(17-18):822-36

Full Text

Abstract

Cigarette smoke and α,β-unsaturated aldehydes elicit VEGF release through the p38 MAPK pathway in human airway smooth muscle cells and lung fibroblasts.

Maurizio Civelli, Riccardo Patacchini, Nadia Moretto, Giorgia Volpi, Fabrizio Facchinetti

British journal of pharmacology 2011;163(3):649-61

Free Full Text

Abstract

Investigational medications for treatment of patients with Alzheimer disease.

Pamela E Potter

The Journal of the American Osteopathic Association 2011;110(9 Suppl 8):S27-36

Full Text

Abstract

Results: 1 – 8 / 8

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Nicotinic Antagonists""[mesh_terms]

Single-Disulfide Conopeptide Czon1107, an Allosteric Antagonist of the Human α3β4 Nicotinic Acetylcholine Receptor.

Human nicotinic receptors in chromaffin cells: characterization and pharmacology.

The Structural Features of α-Conotoxin Specifically Target Different Isoforms of Nicotinic Acetylcholine Receptors.

Identification of a negative allosteric site on human α4β2 and α3β4 neuronal nicotinic acetylcholine receptors.

Mechanistic contributions of residues in the M1 transmembrane domain of the nicotinic receptor to channel gating.

alpha7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and Mesothelioma?

Cigarette smoke and α,β-unsaturated aldehydes elicit VEGF release through the p38 MAPK pathway in human airway smooth muscle cells and lung fibroblasts.

Investigational medications for treatment of patients with Alzheimer disease.

Results for
""Nicotinic Antagonists""[mesh_terms]